Wave Life Sciences (WVE) Revenue (2015 - 2026)

Wave Life Sciences (WVE) has 12 years of Revenue data on file, last reported at $2.3 million in Q2 2026.

• Quarterly Revenue fell 73.88% year-over-year to $2.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $58.4 million (up 16.54% YoY) and the FY2025 annual result came in at $42.7 million, down 60.55% from the prior year.
• Revenue slipped to $2.3 million in Q2 2026, from $38.2 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $49.2 million in Q3 2023 to a low of $285000.0 in Q3 2022.
• A 5-year average of $14.8 million and a median of $10.9 million in 2024 frame the typical range for Revenue.
• Annual changes were most pronounced in 2022 — Revenue slumped 99.22% — and 2023, when it surged 17168.07%.
• Tracing WVE's Revenue over 5 years: stood at $1.2 million in 2022, then surged by 2245.12% to $29.1 million in 2023, then plunged by 32.23% to $19.7 million in 2024, then tumbled by 55.82% to $8.7 million in 2025, then tumbled by 73.88% to $2.3 million in 2026.
• The last three Revenue figures came in at $2.3 million (Q2 2026), $38.2 million (Q1 2026), and $8.7 million (Q2 2025), per Business Quant data.